• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mortality in COVID-19 is not merely a question of resource availability.

作者信息

Becher Tobias, Frerichs Inéz

机构信息

Department of Anesthesiology and Intensive Care Medicine, University Medical Center Schleswig-Holstein, Kiel D-24105, Germany.

Department of Anesthesiology and Intensive Care Medicine, University Medical Center Schleswig-Holstein, Kiel D-24105, Germany.

出版信息

Lancet Respir Med. 2020 Sep;8(9):832-833. doi: 10.1016/S2213-2600(20)30312-X. Epub 2020 Jul 28.

DOI:10.1016/S2213-2600(20)30312-X
PMID:32735840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7386881/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442b/7386881/c0b46954aa50/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442b/7386881/c0b46954aa50/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442b/7386881/c0b46954aa50/fx1_lrg.jpg

相似文献

1
Mortality in COVID-19 is not merely a question of resource availability.新冠病毒肺炎的死亡率不仅仅是资源可及性的问题。
Lancet Respir Med. 2020 Sep;8(9):832-833. doi: 10.1016/S2213-2600(20)30312-X. Epub 2020 Jul 28.
2
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2.SARS-CoV-2 引起的 COVID-19 肺炎患者的死亡预测因素。
Eur Respir J. 2020 Sep 24;56(3). doi: 10.1183/13993003.02439-2020. Print 2020 Sep.
3
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2.SARS-CoV-2 引起的 COVID-19 肺炎患者的死亡预测因子。
Eur Respir J. 2020 Sep 24;56(3). doi: 10.1183/13993003.02961-2020. Print 2020 Sep.
4
Temperature-dependent surface stability of SARS-CoV-2.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的温度依赖性表面稳定性
J Infect. 2020 Sep;81(3):452-482. doi: 10.1016/j.jinf.2020.05.074. Epub 2020 Jun 3.
5
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.新型冠状病毒肺炎患者肺部的组织病理学变化及严重急性呼吸综合征冠状病毒2免疫染色
Ann Intern Med. 2020 Aug 18;173(4):324. doi: 10.7326/L20-0895.
6
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.一名新冠肺炎患者肺部的组织病理学变化及严重急性呼吸综合征冠状病毒2免疫染色
Ann Intern Med. 2020 Aug 18;173(4):323-324. doi: 10.7326/L20-0894.
7
Covid-19 mortality in Italian doctors.意大利医生中的新冠病毒肺炎死亡率
J Infect. 2020 Aug;81(2):e106-e107. doi: 10.1016/j.jinf.2020.05.034. Epub 2020 May 21.
8
Flattening the curve of new publications on COVID-19.平缓新冠疫情相关新出版物的增长曲线。
J Epidemiol Community Health. 2020 Sep;74(9):766-767. doi: 10.1136/jech-2020-214617. Epub 2020 Jul 6.
9
COVID-19: Outcomes of patients with confirmed COVID-19 re-admitted to hospital.新冠病毒病（COVID-19）：确诊感染新冠病毒病后再次入院患者的治疗结果
J Infect. 2020 Sep;81(3):e18-e19. doi: 10.1016/j.jinf.2020.07.007. Epub 2020 Jul 8.
10
The value of serology testing to manage SARS-CoV-2 infections.血清学检测在管理 SARS-CoV-2 感染中的价值。
Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.02411-2020. Print 2020 Aug.

引用本文的文献

1
Comparison of SARS-CoV-2 related in-hospital mortality, ICU admission and mechanical ventilation of 1.4 million patients in Germany and Switzerland, 2019 to 2022.2019年至2022年德国和瑞士140万例患者中与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）相关的院内死亡率、重症监护病房（ICU）入院率和机械通气情况比较
Infection. 2025 Jun;53(3):981-989. doi: 10.1007/s15010-024-02412-9. Epub 2024 Oct 17.
2
The Distinct Regulation of the Vitamin D and Aryl Hydrocarbon Receptors in COVID-19.新冠病毒中维生素D受体和芳烃受体的独特调控
Nutrients. 2024 Feb 22;16(5):598. doi: 10.3390/nu16050598.
3
High variability of COVID-19 case fatality rate in Germany.

本文引用的文献

1
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study.10021 例新冠肺炎住院患者的病例特征、资源利用和结局：一项观察性研究。
Lancet Respir Med. 2020 Sep;8(9):853-862. doi: 10.1016/S2213-2600(20)30316-7. Epub 2020 Jul 28.
2
Potential for Lung Recruitment and Ventilation-Perfusion Mismatch in Patients With the Acute Respiratory Distress Syndrome From Coronavirus Disease 2019.新型冠状病毒病所致急性呼吸窘迫综合征患者的肺复张潜力和通气-灌注不匹配。
Crit Care Med. 2020 Aug;48(8):1129-1134. doi: 10.1097/CCM.0000000000004386.
3
Dexamethasone in Hospitalized Patients with Covid-19.
德国 COVID-19 病死率的高度变异性。
BMC Public Health. 2023 Mar 2;23(1):416. doi: 10.1186/s12889-023-15112-0.
4
Acute tubulointerstitial nephritis and COVID-19.急性肾小管间质性肾炎与新型冠状病毒肺炎
Clin Kidney J. 2021 Jul 11;14(10):2151-2157. doi: 10.1093/ckj/sfab107. eCollection 2021 Oct.
5
Epidemiologic and Clinic Characteristics of the First Wave of the COVID-19 Pandemic in Hospitalized Patients from Galați County.加拉茨县住院患者中新冠疫情第一波的流行病学和临床特征
J Clin Med. 2021 Sep 17;10(18):4210. doi: 10.3390/jcm10184210.
6
Addressing the 'hypoxia paradox' in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues.解决重症 COVID-19 中的“缺氧悖论”：文献回顾和四例接受促红细胞生成素类似物治疗的病例报告。
Mol Med. 2021 Sep 26;27(1):120. doi: 10.1186/s10020-021-00381-5.
7
Identification of Immune Activation Markers in the Early Onset of COVID-19 Infection.鉴定 COVID-19 感染早期的免疫激活标志物。
Front Cell Infect Microbiol. 2021 Sep 3;11:651484. doi: 10.3389/fcimb.2021.651484. eCollection 2021.
8
Predicting mortality in SARS-COV-2 (COVID-19) positive patients in the inpatient setting using a novel deep neural network.利用新型深度神经网络预测住院 SARS-COV-2（COVID-19）阳性患者的死亡率。
Int J Med Inform. 2021 Oct;154:104556. doi: 10.1016/j.ijmedinf.2021.104556. Epub 2021 Aug 21.
9
[Medical students as helpers in the pandemic : Innovative concept for recruitment, training and assignment planning of medical students as medical personnel during the COVID-19 pandemic].[医学生在疫情期间担任助手：新冠疫情期间医学生作为医务人员的招募、培训和任务分配计划的创新概念]
Anaesthesist. 2022 Jan;71(1):21-29. doi: 10.1007/s00101-021-01009-3. Epub 2021 Jul 20.
10
Trends in COVID-19 case-fatality rates in Brazilian public hospitals: A longitudinal cohort of 398,063 hospital admissions from 1st March to 3rd October 2020.2020 年 3 月 1 日至 10 月 3 日巴西公立医院 COVID-19 病死率趋势：一项对 398,063 例住院患者的纵向队列研究。
PLoS One. 2021 Jul 16;16(7):e0254633. doi: 10.1371/journal.pone.0254633. eCollection 2021.
地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
4
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.瑞德西韦治疗新冠病毒病-初步报告。回复。
N Engl J Med. 2020 Sep 3;383(10):994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.
5
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
6
Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series.德国一起旅行相关原发性病例引发的 COVID-19 暴发调查：病例系列研究。
Lancet Infect Dis. 2020 Aug;20(8):920-928. doi: 10.1016/S1473-3099(20)30314-5. Epub 2020 May 15.
7
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区，5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
8
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
9
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.